Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Julie Parsonnet and Upinder Singh.
Julie Parsonnet
Connection Strength
0.414
Upinder Singh
  1. Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial. Nat Commun. 2021 03 30; 12(1):1967.
    View in: PubMed
    Score: 0.234
  2. Interferon-? Release Assay for Accurate Detection of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Response. Clin Infect Dis. 2021 11 02; 73(9):e3130-e3132.
    View in: PubMed
    Score: 0.061
  3. The COVID-19 Outpatient Pragmatic Platform Study (COPPS): Study design of a multi-center pragmatic platform trial. Contemp Clin Trials. 2021 09; 108:106509.
    View in: PubMed
    Score: 0.060
  4. SARS-CoV-2 Subgenomic RNA Kinetics in Longitudinal Clinical Samples. Open Forum Infect Dis. 2021 Jul; 8(7):ofab310.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.